Back to search
FDAFDA · Food and drugs·Recall number D-0923-2017

Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8

Published July 5, 2017 · Recall initiated: April 27, 2017

Summary

FDA records drug Class III recall D-0923-2017, published July 5, 2017 and initiated April 27, 2017. Recalling firm: Noven Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 14434 cartons; Lot: Lot #:: 78618, Exp. 05/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

What to do

Voluntary: Firm initiated · Letter

Get an email if MINIVELLE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MINIVELLE
Manufacturer
Noven Pharmaceuticals, Inc.
Distributor
Nationwide within US
UPC
0368968665083
Lot
Lot #:: 78618, Exp. 05/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8 recalled?

Yes. FDA published recall D-0923-2017 on July 5, 2017. Reported hazard: Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MINIVELLE. UPC: 0368968665083.